Transcriptomic profiling identifies ADAM23, a cell-adhesion-related tumor suppressor, as a METTL3-dependent, m<sup>6</sup>A-associated transcript, with altered mRNA expression observed across multiple experimental systems and several high-confidence predicted m<sup>6</sup>A sites within its transcript. This evidence concerns the gene METTL3 and neoplasm.